View Agent
| Agent Info | |
| Agent: | necitumumab |
| Synonyms: | LY3012211 |
| Drug Status For Certain Diseases: | Squamous non-small-cell lung cancer(phase III);Colorectal cancer(phase III);Non-small-cell lung carcinoma(phase III) |
| Classification: | a second-generation, recombinant, human immunoglobulin G1 EGFR antibody |
| Target: | Epidermal growth factor receptor |
| KEGG Pathway: | NA |
| Wiki Pathway: | Bladder Cancer Gastrin-CREB signalling pathway via PKC and MAPK Spinal Cord Injury miR-targeted genes in muscle cell - TarBase PIP3 activates AKT signaling Arylhydrocarbon receptor (AhR) signaling pathway Signaling by ERBB4 L1CAM interactions ErbB Signaling Pathway miR-targeted genes in lymphocytes - TarBase Regulation of Actin Cytoskeleton MAPK Signaling Pathway TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer AGE/RAGE pathway miR-targeted genes in epithelium - TarBase Gastric cancer network 2 Signaling by EGFR Focal Adhesion Extracellular vesicle-mediated signaling in recipient cells Hair Follicle Development Hair Follicle Development Signaling by ERBB2 Nanoparticle-mediated activation of receptor signaling Aryl Hydrocarbon Receptor Integrated Pancreatic Cancer Pathway Signaling Pathways in Glioblastoma Integrated Breast Cancer Pathway EGF/EGFR Signaling Pathway Aryl Hydrocarbon Receptor Pathway |